Back
Syndax Pharmaceuticals Vs. Deciphera Pharmaceuticals Industry Stock Comparison
Buy
58
SNDX
Syndax Pharmaceuticals
Last Price:
23.78
Seasonality Move:
13.83%
Sell
34
DCPH
Deciphera Pharmaceuticals
Last Price:
15.73
Seasonality Move:
26.33%
Buy
58
Syndax Pharmaceuticals (SNDX)
is a Buy
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $23.07. The Score for SNDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SNDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Deciphera Pharmaceuticals (DCPH)
is a Sell
Is Deciphera Pharmaceuticals a Buy, Sell or Hold?
- The current Deciphera Pharmaceuticals [DCPH] share price is $15.19. The Score for DCPH is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- DCPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $23.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DCPH Stock Price Chart
What is Deciphera Pharmaceuticals's stock price today?
-
The Deciphera Pharmaceuticals share price today is $15.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DCPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 51.78 | Buy |
Chaikin Money Flow: | 777916 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.46 - 23.98) | Sell |
Bollinger Bands (100): | (17.02 - 23.34) | Buy |
DCPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 44.79 | Sell |
Chaikin Money Flow: | 204610 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.33 - 16.83) | Sell |
Bollinger Bands (100): | (13.11 - 16.29) | Buy |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.44 | Buy |
20-day SMA: | 23.1 | Sell |
50-day SMA: | 22.32 | Buy |
200-day SMA: | 18.97 | Buy |
8-day EMA: | 22.6 | Buy |
20-day EMA: | 22.81 | Buy |
50-day EMA: | 22.19 | Buy |
200-day EMA: | 20.14 | Buy |
DCPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.2 | Sell |
20-day SMA: | 16 | Sell |
50-day SMA: | 15.38 | Sell |
200-day SMA: | 13.99 | Buy |
8-day EMA: | 15.31 | Sell |
20-day EMA: | 15.62 | Sell |
50-day EMA: | 15.46 | Sell |
200-day EMA: | 14.58 | Buy |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and an increase next year of $1.07 per share.
Deciphera Pharmaceuticals Earnings Growth & DCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.43 per share.
Syndax Pharmaceuticals Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Deciphera Pharmaceuticals Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |